PACB Stock-Based Compensation
Pacific Biosciences Of California · Stock-Based Compensation
PACB Stock-Based Compensation
Latest reported$23.31Mperiod ending
PACB Stock-Based Comp ($1.66M → $23.31M)
Annual stock-based compensation
High-resolution chart · PNG
PACB stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 41,668,000 | |
| 0 | |
| 0 | |
| 78,613,000 | |
| 80,728,000 | |
| 17,533,000 | |
| 16,401,000 | |
| 23,153,000 | |
| 20,352,000 | |
| 19,562,000 | |
| 13,840,000 | |
| 9,943,000 | |
| 9,905,000 | |
| 9,705,000 | |
| 12,384,000 | |
| 9,690,000 | |
| 3,630,000 | |
| 2,127,000 | |
| 1,660,000 |